Cadranel, Jean-Francois

Publishing since 1986 (Dinosaur)

Has published 164 publications in 25 years

Number of publications published per year by Cadranel, Jean-Francois. (Source : PubMed)

Distribution of publications types for Cadranel, Jean-Francois. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Morin T, Pariente A, Lahmek P, Rabaud C, Silvain C, Cadranel JF. Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort.  Eur J Gastroenterol Hepatol  2010;22;2  
•  Jouannaud V, Cadranel JF, Dumouchel P, Cazier A, Capron D, Rochette J, Barbare JC. Marked iron overload related to ribavirin and iron sulfate treatment in a patient with active viral C cirrhosis.  Eur J Gastroenterol Hepatol  2009;21;11  
•  Renou C, Nicand E, Pariente A, Cadranel JF, Pavio N. [How to detect and diagnose an autochthonous hepatitis E?]  Gastroenterol. Clin. Biol.  2009;33;10-11 Suppl  
•  Nahon S, Cadranel JF, Chazouilleres O, Biour M, Jouannaud V, Marteau P. Liver and inflammatory bowel disease.  Gastroenterol. Clin. Biol.  2009;33;5  
•  Cadranel JF, Seddik M, Loric S, Jeanne S. [Statins: hepatotoxicity and monitoring]  Presse Med  2009;38;5  
•  Morin T, Pariente A, Cadranel JF, Denis J. Role of nosocomial hospital transmission in acute hepatitis C.  J. Hepatol.  2009;50;1  
•  Renou C, Cadranel JF, Pariente A, Pénaranda G, Bourlière M, Halfon P, Igual JP, Harafa A, Muller P, Bertrand JJ, Laugier R. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers.  Eur J Gastroenterol Hepatol  2008;20;12  
•  Peyrin-Biroulet L, Cadranel JF, Nousbaum JB, Oussalah A, Seddik M, Canva V, Cortot A, Sogni P, Gueant JL, Bigard MA, Roblin X, Bronowicki JP. Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression.  Aliment. Pharmacol. Ther.  2008;28;8  
•  Cadranel JF, Demontis R, Seddik M, Ramdani S, Belloula D, Biour M. [Hepatic and renal toxicity to fluindione (Previscan((R))).]  Gastroenterol. Clin. Biol.  2008  
•  Cadranel JF, Di Martino V, Lambrey G, Mourlhon C, Nalet B, Anciaux ML, Richard C, Bigué JP, Barjon JN, Bories C, Barbare JC, Halimi C, Ribière O, Eugène C, Pauwels A, Jeanne S, Donato L, Dumouchel P, Pariente A, Duverlie G, Devergie B, Arlot S, Capron D. Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study.  Eur J Gastroenterol Hepatol  2008;20;9  

[ See timeline ] [ See all publications ]